Helmut
★★★
avatar
Homepage
Vienna, Austria,
2012-08-23 19:57
(4235 d 08:31 ago)

Posting: # 9099
Views: 3,348
 

 FDA: GDUFA / D-U-N-S Number [BE/BA News]

Dear all,

THX to Ohlbe who suggested to come up with this goodie.

Go for it if #4 is applicable* (which was not required before); otherwise the penalty is nasty:

Under GDUFA, if a facility fails to self-identify, all FDF or API products manufactured at the facility and all FDFs containing APIs manufactured at the facility will be deemed misbranded. It is a violation of federal law to ship misbranded products in interstate commerce or to import them into the United States. Such violations can result in prosecution of those responsible, injunctions, or seizures of the misbranded products. Products that are deemed misbranded because of failure of the facility to self-identify are subject to being denied entry into the United States.



  • The following types of generic industry facilities, sites, and organizations are required to self-identify with FDA:
    #4. Bioequivalence (BE)/bioavailability (BA) sites that are identified in a generic drug submission and conduct clinical BE/BA testing, bioanalytical testing of samples collected from clinical BE/BA testing, and/or in vitro BE testing.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
86 visitors (0 registered, 86 guests [including 4 identified bots]).
Forum time: 03:29 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5